NCT01293305

Study With Chondroitin Sulfate and Glucosamine Sulfate (in Dosage Capsule and Sachet) in Treating Osteoarthritis

Randomized Evaluation Of Not Less Medical Association Chondroitin Sulfate Plus Glucosamine Sulfate (In Powder Dosage Forms And Oral Capsule), Manufactured By The Geolab Pharmaceutical Industry Ltd, Compared To The Drug Condroflex® (Powder And Oral Capsule), Manufactured In The Laboratory Zodiac, The Treatment Of Osteoarthritis.

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 320 (estimated)
• Sponsor: Azidus Brasil · Industry
• Sex: All
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

The use of chondroitin sulfate and glucosamine sulfate has been recognized since the 70 decade in the treatment of osteoarthritis. Numerous clinical trials have demonstrated the therapeutic properties of this association in control of osteoarthritis, especially in reducing pain and improving movement. The combination of chondroitin sulfate with glucosamine sulfate offers a significantly higher tolerance than most drug treatments and, moreover, has long lasting effects even after stopping treatment.

Conditions

• Osteoarthritis

Interventions

Type	Name	Description
DRUG	Chondroitin sulfate + Glucosamine sulfate	1 capsule three times daily, preferably in the same period
DRUG	Chondroitin sulfate + Glucosamine sulfate	1 sachet per day of the drug dissolved in a beaker with 200 mL water.

Timeline

• Start date: 2011-11-01
• Primary completion: 2012-08-01
• Completion: 2012-12-01
• First posted: 2011-02-10
• Last updated: 2011-02-10